Approval · Notice of Compliance 18454 · 2016
MAR-AZITHROMYCIN: Notice of Compliance 18454
Issued September 8, 2016
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 18454
- Date
- September 8, 2016
- Company
- Marcan Pharmaceuticals Inc.Ottawa, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Licensing agreement between two companies
- Canadian reference product
- ZITHROMAX (Pfizer Canada Ulc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MAR-AZITHROMYCIN | 02452324 | Marketed |
| MAR-AZITHROMYCIN | 02452332 | Approved |
Medicinal ingredients
- AZITHROMYCIN DIHYDRATE 250 MG per TAB
- AZITHROMYCIN DIHYDRATE 600 MG per TAB